Ann Pediatr Endocrinol Metab.  2023 Mar;28(1):61-66. 10.6065/apem.2142108.054.

Pediatric management challenges of hyperglycemic hyperosmolar state: case series of Korean adolescents with type 2 diabetes

• Lee S
• Yoo S
• Yoon JY
• Cheon CK
• Kim YA

• KMID: 2540789
• DOI: http://doi.org/10.6065/apem.2142108.054

Abstract

The hyperglycemic hyperosmolar state (HHS) is considered the most fatal complication of type 2 diabetes mellitus (DM). The number of case reports describing pediatric HHS has increased recently in parallel with obesity and the prevalence of type 2 DM in pediatric patients. In this study, we investigated the patient characteristics and outcomes of HHS in 9 adolescents with obesity and type 2 DM. Almost all patients exhibited mixed clinical features of HHS and diabetic ketoacidosis (DKA), including characteristics such as hyperosmolality and ketoacidosis. These features made definitive diagnosis difficult; 5 out of 9 patients were initially diagnosed with DKA and were treated accordingly. Patients who were initially diagnosed with HHS received a more vigorous and appropriate fluid replacement than other patients did. No patients died, although 3 exhibited complications, such as arrhythmia, acute kidney injury requiring renal replacement therapy, rhabdomyolysis, and acute pancreatitis. Hyperosmolality with consequent severe dehydration is considered a significant factor contributing to the outcomes of patients with HHS. Therefore, early recognition of hyperosmolality is crucial for an appropriate diagnosis and adequate fluid rehydration to restore perfusion in the early period of treatment to improve patient outcomes for this rare but serious emerging condition in pediatric patients.

Keyword

Hyperglycemic hyperosmolar state; Pediatrics; Type 2 diabetes mellitus; Hyperosmolality; Ketoacidosis

Figure

• 

  Fig. 1. The time course of the proportion of fluid quantity administered among actual replaced fluid volume (A) laboratory findings, including blood glucose level (B), serum osmolality (C), and for 48 hours of treatment.

Reference

References

1. Zeitler P, Haqq A, Rosenbloom A, Glaser N; Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr. 2011; 158:9–14. 14.e1-2.

2. Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2017; 96:729–36.

3. Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014; 37:3124–31.

4. Bagdure D, Rewers A, Campagna E, Sills MR. Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA. Pediatr Diabetes. 2013; 14:18–24.

5. Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010; 156:180–4.

6. Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, et al. Presentation of youth with type 2 diabetes in the pediatric diabetes consortium. Pediatr Diabetes. 2016; 17:266–73.

7. Han J, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010; 375:1737–48.

8. Kim JH, Moon JS. Secular trends in pediatric overweight and obesity in Korea. J Obes Metab Syndr. 2020; 29:12–7.

9. Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA, Tamborlane WV. Decompensated hyperglycemic hyper­osmolarity without significant ketoacidosis in the adolescent and young adult population. J Pediatr Endocrinol Metab. 2007; 20:1115–24.

10. Hong EH, Park JS, Lee HS, Cho MH, Ko CW. Clinical characteristics and laboratory findings of children who were newly diagnosed with diabetes mellitus (from 2001 to 2008). J Korean Soc Pediatr Endocrinol. 2009; 14:110–5.

11. Kim TY, Ahn J, Kim HS. Hyperglycemic hyperosmolar state in children with type 2 diabetes mellitus: a report of two cases. J Korean Soc Pediatr Endocrinol. 2009; 14:73–7.

12. Yu J, Jin H, Ko J, Kang H. A case of severe diabetic ketoacidosis in a child with type 2 diabetes. J Korean Soc Pediatr Endocrinol. 2011; 16:46–50.

13. Kim JH, Choi E, Rhie YJ, Lee JH, Lee KH, Nam HK. Diabetic ketoacidosis with hyperglycemic hyperosmolar state at the onset of type 2 diabetes mellitus in an adolescent male. Soonchunhyang Med Sci. 2016; 22:158–62.

14. Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19:155–77.

15. Agrawal S, Baird GL, Quintos JB, Reinert SE, Gopalakrishnan G, Boney CM, et al. Pediatric diabetic ketoacidosis with hyperosmolarity: clinical characteristics and outcomes. Endocr Pract. 2018; 24:726–32.

16. Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care. 2020; 43:349–57.

17. Schmitt J, Rahman AF, Ashraf A. Concurrent diabetic ketoacidosis with hyperosmolality and/or severe hyperglycemia in youth with type 2 diabetes. Endocrinol Diabetes Metab. 2020; 3:e00160.

18. Wu XY, She DM, Wang F, Guo G, Li R, Fang P, et al. Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period. BMC Endocr Disord. 2020; 20:182.

19. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32:1335–43.

20. Scott AR; Joint British Diabetes Societies (JBDS) for Inpatient Care; JBDS hyperosmolar hyperglycaemic guidelines group. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med. 2015; 32:714–24.